Researchers measure drop in cancer detection in Ontario due to COVID-19

KU Cancer Center deploys new mobile cancer screening bus

The University of Kansas Cancer Center and its outreach network, the Masonic Cancer Alliance, announced a new effort to provide cancer screening throughout the cancer center’s catchment area. Known as HOPE on Wheels: Health, Outreach, Prevention, and Education, a 42-foot bus will help ensure that geography isn’t a barrier to detecting cancers earlier.

March 20, 2026

Vol.52 No.11

Podcast

With five-year cancer survival at an all-time high, does this mean people are living longer?

“It's really, really important that every year since 1991, cancer mortality has dropped by a little bit, and it did again!” said Paul Goldberg, editor and publisher of The Cancer Letter. “Now, mortality is a good metric, age-adjusted mortality. As far as survival, well, that's not so good.”

January 21, 2026

Clinical Health Equity

New Medicaid work requirements could lead to 1.6 million missed cancer screenings over two years

New Medicaid work requirements included in President Donald Trump’s “One Big Beautiful Bill Act” could result in as many as 1.6 million missed screenings for breast, colon, and lung cancers within the first two years, researchers at the University of Chicago reported in a paper published in JAMA Oncology earlier this month.

Could mRNA vaccines hold the key to building an affordable universal cancer vaccine?

“I believe in the concept of a universal cancer vaccine,” said Elias Sayour, a pediatric oncologist at the University of Florida. “I think if this fails in a prospective phase III trial, I still believe we can engineer a vaccine that works prospectively.”

January 14, 2026

Vol.52 No.1

Clinical

A planned randomized trial will ask an intriguing question: Do COVID vaccines potentiate checkpoint inhibitors?

A phase III clinical trial will soon begin testing the evidence collected thus far that points to a stunning prospect: the COVID-19 vaccine—a widely accessible mRNA vaccine already on the market—could make checkpoint inhibitors work better for lung cancer and melanoma patients.

January 09, 2026

Vol.52 No.1

By Sara Willa Ernst and Jacquelyn Cobb

Clinical Roundup

Blood test may help identify which colon cancer patients benefit from NSAIDs

A blood test could help doctors decide which patients with colon cancer should receive anti-inflammatory medication along with chemotherapy after surgery.

January 09, 2026

Vol.52 No.1

Researchers measure drop in cancer detection in Ontario due to COVID-19

YOU MAY BE INTERESTED IN

KU Cancer Center deploys new mobile cancer screening bus

With five-year cancer survival at an all-time high, does this mean people are living longer?

New Medicaid work requirements could lead to 1.6 million missed cancer screenings over two years

Could mRNA vaccines hold the key to building an affordable universal cancer vaccine?

A planned randomized trial will ask an intriguing question: Do COVID vaccines potentiate checkpoint inhibitors?

Blood test may help identify which colon cancer patients benefit from NSAIDs

Renew today!

Subscriber content

Never miss an issue!

Login